---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048082"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2024-11-29T23:59:59+00:00"
generated_at: "2026-05-29T12:59:04.815502+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Celularity receives Nasdaq delisting notice for late Q3 2024 10-Q filing

## Summary
- Failed to file Q3 2024 10-Q by Nov 19 extension; Nasdaq issued non-compliance notice on Nov 21, 2024.
- No immediate effect on CELU/CELUW trading; must submit compliance plan by Jan 20, 2025.
- If plan accepted, compliance deadline extended to May 13, 2025. No assurance of regaining compliance.
- Delay attributed to incomplete preparation of financial statements for Q3 2024.

## SEC filing metadata
- accession: 0001493152-24-048082
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2024-11-29T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315224048082/0001493152-24-048082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315224048082/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048082
- JSON: https://secwatch.observer/filing/0001493152-24-048082.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048082.txt

## Key facts
- Listing & Compliance Notices
  Celularity Inc received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: November 21, 2024, the Company informed the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) that it failed to timely file its Q3 2024 Form 10-Q within the extension period provided by Rule 12b-25 because the Company had not yet completed the preparation of the financial statements. On November 21, 2024, Nasdaq provided formal notice to the Company that as a result of the Company’s failure to timely file its Q3 2024 10-Q, it no longer complied with the continued listing requirements under the timely filing criteria outlined in Nasdaq Listing Rule 5250(c)(1). Nasdaq’s
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000149315224048082/0001493152-24-048082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.